![Erich Tauber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Erich Tauber is the founder and current Chief Executive Officer of Themis Bioscience GmbH, which is founded in 2009.
Dr. Tauber is also the founder of Themis Bioscience NV.
He previously worked as Vice President at Intercell AG.
Postes actifs de Erich Tauber
Sociétés | Poste | Début |
---|---|---|
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Directeur Général | 01/01/2009 |
Themis Bioscience NV
![]() Themis Bioscience NV BiotechnologyHealth Technology Themis Bioscience NV operates as biotechnology company. The firm engages in immunomodulation therapies for infectious diseases. The company is headquartered in Amsterdam, the Netherlands. | Directeur Général | - |
Anciens postes connus de Erich Tauber
Sociétés | Poste | Fin |
---|---|---|
Intercell AG
![]() Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Intercell AG
![]() Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Health Technology |
Themis Bioscience GmbH
![]() Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Health Technology |
Themis Bioscience NV
![]() Themis Bioscience NV BiotechnologyHealth Technology Themis Bioscience NV operates as biotechnology company. The firm engages in immunomodulation therapies for infectious diseases. The company is headquartered in Amsterdam, the Netherlands. | Health Technology |